TGF-β/β2-spectrin/CTCF-regulated tumor suppression in human stem cell disorder Beckwith-Wiedemann syndrome.
Document Type
Journal Article
Publication Date
2-1-2016
Journal
The Journal of clinical investigation
Volume
126
Issue
2
DOI
10.1172/JCI80937
Keywords
Animals; Beckwith-Wiedemann Syndrome; CCCTC-Binding Factor; Carrier Proteins; Chromosomes, Human, Pair 11; Cyclin-Dependent Kinase Inhibitor p57; Hep G2 Cells; Humans; Insulin-Like Growth Factor II; KCNQ1 Potassium Channel; Mice; Mice, Knockout; Microfilament Proteins; Neoplasm Proteins; Neoplasms; Repressor Proteins; Signal Transduction; Smad3 Protein; Telomerase; Transforming Growth Factor beta
APA Citation
Chen, J., Yao, Z., Chen, J., Gi, Y., Muñoz, N., Kundra, S., Herlong, H., Jeong, Y., Goltsov, A., Ohshiro, K., Mistry, N., Zhang, J., Su, X., Choufani, S., Mitra, A., Li, S., Mishra, B., White, J., Rashid, A., Wang, A., Javle, M., Davila, M., Michaely, P., Weksberg, R., Hofstetter, W., Finegold, M., Shay, J., Machida, K., Tsukamoto, H., & Mishra, L. (2016). TGF-β/β2-spectrin/CTCF-regulated tumor suppression in human stem cell disorder Beckwith-Wiedemann syndrome.. The Journal of clinical investigation, 126 (2). http://dx.doi.org/10.1172/JCI80937
Peer Reviewed
1
